Data IntegrationProcess AutomationPharmacovigilanceGeneticsOphthalmologyRheumatologyHealth DiagnosticsPain ManagementVaccinesSoftware DevelopmentOncologyBiopharmaBiotechnologyHealth CareInformation TechnologyPharmaceutical
Description
McKesson Corporation (‘McKesson’), together with its subsidiaries, operates as a diversified healthcare service company.
The company’s teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deli…
Analysis
Middle-of-the-road
McKesson Corporation is a middle-of-the-road business: neither the economics nor the price stand out from the peer group. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is fair. You pay 19.2× its owner earnings: the cash an owner could take out each year, which is in the historically fair zone. At today's price, the market is assuming roughly 6% yearly growth; analysts expect 14%. The price, in other words, assumes less than the experts do.
The trajectory is solid and the balance sheet is sturdy. The company scores 18/20 on our value-creation score: strong value creator.
What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202369
75
2023202420252026
All-time high
100
Dec 2025
All-time low
49
Feb 2026
Average rank
86
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
97
87
91
91
Price/Earnings
33
49
51
86
Price/Book
1
100
100
3
Dividend Yield
81
72
73
67
Value (overall)
63
92
93
92
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.